Well, this can be the beginning of the end of eating radioactive material.. No more mixing cesium with food for gastric emptying studies. This new technology, by SmartPill Corp we covered earlier, has just received FDA approval. The company, a leader in developing capsule-based medical devices, based in Buffalo,N.Y., was granted an FDA green light for use and sale of its SmartPill pH.p Capsule and SmartPill GI Monitoring in the United States.
“”FDA approval means GI professionals who treat patients with slow gastric emptying now have a new alternative when it comes to diagnosing their patients,” said Dr. Braden Kuo, chairman of SmartPill’s scientific advisory board and an instructor at Harvard Medical School and Assistant in Medicine, Department of Internal Medicine, Massachusetts General Hospital.”
The SmartPill pH.p Capsule is a wireless, ingestible medical device – about the size of a large vitamin pill – that measures pressure and pH, gastric emptying time, combined small and large bowel transit time, and total transit time.
The Capsule travels through the gastrointestinal (GI) tract, collecting and transmitting data to the SmartPill Data Receiver. The receiver, slightly larger than a cell phone, is worn on a patient’s belt or around the neck on a lanyard.
Patients can take the test right in their physicians’ offices. A patient ingests the single-use SmartPill pH.p Capsule in the doctor’s office and, within a day or two, the disposable capsule is excreted naturally from the body. The patient then returns to the doctor, who downloads the information from the SmartPill Data Receiver.
More from SmartPill Corp.
